Abstract:ABSTRACT Tuberculous meningitis (TBM) is a severe infectious disease affecting the central nervous system, causing high mortality and disability. However, current diagnostic methods for TBM using cerebrospinal fluid (CSF) lack sensitivity and predictive biomarkers for prognosis. We conducted a study on cytokine profiles in CSF and serum samples from TBM patients to identify disease-specific biomarkers. Patients were categorized into three groups: TBM ( n = 17), cryptococcal meningitis ( n = 10), and non-infection ( n = 6), and cytokine levels were quantified using a 48-plex panel. After treatment, we observed a significant reduction in the levels of 12 cytokines, indicating their potential use as biomarkers for treatment monitoring. Among them, monokine induced by interferon-γ (MIG) and interleukin-18 showed significant differences in serum or CSF cytokine levels compared to the control groups. CSF levels of MIG in TBM patients were negatively correlated with the CSF/blood glucose ratio ( r = −0.4728, P = 0.0475). Positive correlations were found between CSF leukocyte counts and several cytokines, including fibroblast growth factor-basic, granulocyte colony-stimulating factor (G-CSF), monocyte chemotactic protein-3, macrophage inflammatory protein 1 alpha (MIP-1α), and tumor necrosis factor alpha. G-CSF and MIP-1α were also positively correlated with CSF protein levels. Receiver operating characteristic curve analysis revealed that MIG exhibited the highest area under the curve of 0.92 [95% confidence interval (CI) 0.82–1.00] with a sensitivity of 0.85 (95% CI 0.58–0.97) and a specificity of 0.87 (95% CI 0.62–0.98), making it a promising diagnostic biomarker for TBM. Our study provides valuable insights into TBM’s pathogenesis and identifies potential biomarkers for diagnosis and evaluating treatment monitoring. IMPORTANCE Tuberculous meningitis is a life-threatening infection with high mortality and disability rates. Current diagnostic methods using cerebrospinal fluid (CSF) samples have limited sensitivity and lack predictive biomarkers for evaluating prognosis. This study’s findings reveal excessive activation of the immune response during tuberculous meningitis (TBM) infection. Notably, a strong negative correlation was observed between CSF levels of monokine induced by interferon-γ (MIG) and the CSF/blood glucose ratio in TBM patients. MIG also exhibited the highest area under the curve with high sensitivity and specificity. This study suggests that MIG may serve as a novel biomarker for differentiating TBM infection in CSF or serum, potentially leading to improved diagnostic accuracy and better patient outcomes.

Expression of Autophagy-Related Genes in Cerebrospinal Fluid of Patients with Tuberculous Meningitis

Elevated Host Lipid Metabolism Revealed by Itraq-Based Quantitative Proteomic Analysis of Cerebrospinal Fluid of Tuberculous Meningitis Patients.

Systemic and cerebrospinal fluid biomarkers for tuberculous meningitis identification and treatment monitoring

Clinical Diagnostic Significance of ESAT-6, IL-10, TNF-α and IFN-γ in Tuberculous Meningitis

Sensitivity and specificity of immunocytochemical staining of mycobacterial antigens in the cytoplasm of cerebrospinal fluid macrophages for diagnosing tuberculous meningitis.

Identification of protein biomarkers in host cerebrospinal fluid for differential diagnosis of tuberculous meningitis and other meningitis

Expression Of Cytokines Il-1 Beta, Il-6 And Tnf-Alpha In Intervertebral Disc Lesions Of Spinal Tuberculosis

Clinical Significance of M1/M2 Macrophages and Related Cytokines in Patients with Spinal Tuberculosis

High cerebrospinal fluid lactate concentration at 48 h of hospital admission predicts poor outcomes in patients with tuberculous meningitis: A multicenter retrospective cohort study

Disease spectrum and prognostic factors in patients treated for tuberculous meningitis in Shaanxi province, China

Cerebrospinal Fluid Metabolomic Profiling in Tuberculous and Viral Meningitis: Screening Potential Markers for Differential Diagnosis

The application value of cerebrospinal fluid immunoglobulin in tuberculous meningitis

Detection of Interleukin-8, Matrix Metalloproteinase-9 and Interferon Gamma Levels in the Cerebrospinal Fluid of Patients with Tuberculous Meningitis and Viral Meningitis

Detection of NSE, MMP-9 and ADA in cerebrospinal fluid applied in diagnosis of tuberculous meningitis

Immunohistochemical analysis of cytokines and apoptosis in tuberculous lymphadenitis

Expression of cytokines IL-1 β , IL-6 and TNF-α in intervertebral disc lesions of spinal tuberculosis

Itraq-Based Quantitative Proteomic Analysis Of Cerebrospinal Fluid Reveals Nell2 As A Potential Diagnostic Biomarker Of Tuberculous Meningitis

The Feasibility of Metagenomic Next-Generation Sequencing to Identify Pathogens Causing Tuberculous Meningitis in Cerebrospinal Fluid

Metabolomic analysis of human cerebrospinal fluid in patients with tuberculous meningitis using ultra high performance liquid chromatography tandem mass spectrometry

MR Angiography Abnormality in Patients with Tuberculous Meningitis: Correlation Factor and Prognostic Significance Analyses

The Defect In Autophagy Induction By Clinical Isolates Of Mycobacterium Tuberculosis Is Correlated With Poor Tuberculosis Outcomes